# Six-months Versus Nine-months ATT for Ocular TB

> **NCT06613919** · PHASE4 · COMPLETED · sponsor: **L.V. Prasad Eye Institute** · enrollment: 58 (actual)

## Conditions studied

- Tuberculosis (TB)
- Uveitis
- Retinal Vasculitis
- Choroiditis

## Interventions

- **DRUG:** Anti-Tuberculosis Treatment
- **DRUG:** Anti-Tuberculosis Treatment

## Key facts

- **NCT ID:** NCT06613919
- **Lead sponsor:** L.V. Prasad Eye Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06613919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06613919, "Six-months Versus Nine-months ATT for Ocular TB". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06613919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*